Gonadotropin-releasing hormone antagonists instead of agonists: A change for the better?

Fertility and Sterility

Volumn 76, Issue 3, 2001, Pages 443-444

  Blumenfeld, Zeev ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GONADORELIN; GONADORELIN ANTAGONIST; GROWTH FACTOR;

CLINICAL TRIAL; DRUG EFFECT; DRUG SAFETY; EDITORIAL; EMBRYO DEVELOPMENT; FEMALE; FERTILIZATION; HUMAN; INFERTILITY; OOCYTE; PREGNANCY RATE; PRIORITY JOURNAL; SIDE EFFECT;

EMBRYO IMPLANTATION; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RECOMBINANT PROTEINS; REPRODUCTIVE TECHNIQUES;

EID: 0034893385     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)01972-0     Document Type: Editorial

References (4)

1. Embryo implantation and GnRH antagonists; embryo implantation: the Rubicon for GnRH antagonists
2. Embryo implantation and GnRH antagonists; GnRH antagonists in ART: lower embryo implantation?
3. Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate
4. Human oviductal gonadotropin-releasing hormone; possible implications in fertilization, early embryonic development, and implantation